ADVERTISEMENT
4 /5 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Frontage buys rival contract research firm

by Michael McCoy
April 16, 2018 | APPEARED IN VOLUME 96, ISSUE 16

 

The contract research organization Frontage Laboratories has acquired rival Concord Biosciences for an undisclosed sum. Frontage’s 650 employees offer drug development services from 14 locations in the U.S. and China. Ohio-based Concord, formerly Ricerca Biosciences, will bolster Frontage’s preclinical, agrochemical, and toxicology services, says Frontage CEO Song Li. Concord has 65 employees. Olon acquired Ricerca’s chemical manufacturing division last year.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment